Carolyn Ann FOSTER,Peter C. HIESTAND,Paul William GLUE
申请号：
US13464294
公开号：
US20120225031A1
申请日:
2012.05.04
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Disclosed are pharmaceutical combinations comprising at least one S1P receptor agonist, as well as a method for treating demyelinating diseases, e.g. multiple sclerosis or disorders associated therewith or Guillain-Barré syndrome, comprising co-administration, e.g. concomitantly or in sequence, of a therapeutically effective amount of a) an S1P receptor agonist, and b) at least one co-agent shown to have clinical activity against at least one symptom of a demyelinating disease.
